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Background: Dignity therapy is a brief psychotherapy that has been shown to enhance the end of life experience.
Dignity therapy often involves family carers to support patients weakened by illness and family carers are also the
usual recipients of the legacy documents created. No research to date has examined the impact of dignity therapy
on family carers at the time of the intervention. This study examined the effects of dignity therapy on family carers
of people with motor neurone disease (MND).
Methods: This is a cross-sectional study utilizing a one-group pre-test post-test design with 18 family carers of
people diagnosed with MND. Outcomes measured caregiver burden, anxiety, depression, and hopefulness.
Acceptability was measured with a questionnaire. Feasibility was assessed by examining family carers’ involvement
in the therapy sessions, time taken to conduct sessions, and any special accommodations or deviations from the
dignity therapy protocol.
Results: There were no significant pre-test post-test changes on the group level, but there were decreases in
anxiety and depression on the individual level. Baseline measures indicate that 50% of family carers had moderate
to severe scores for anxiety prior to dignity therapy. MND family carers saw benefits to the person with MND and
to themselves after bereavement, but acceptability of dignity therapy at the time of the intervention was mixed
with some family carers indicating it was helpful, some indicating it was harmful, and many expressing ambivalence.
Dignity therapy involving MND family carers is feasible and the involvement of family carers has minimal impact on
the therapy.
Conclusion: Dignity therapy is not likely to alleviate caregiver burden in MND family carers, but it may have the
ability to decrease or moderate anxiety and depression in distressed MND family carers. Dignity therapy is feasible
and generally acceptable to MND family carers. Dignity therapists may provide a better experience for family carers
when they are aware of acceptance levels and the quality of partner relationships.
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Dignity therapy is a brief psychotherapeutic intervention
which has been shown to enhance the end of life experi-
ence in people with life-limiting conditions [1]. In a dis-
tressed group of terminally ill patients, dignity therapy
has been shown to reduce anxiety and depression [2].
Dignity therapy is based on a theoretical model of dig-
nity in the terminally ill [3] and its purpose is to reduce
dignity-related distress while enhancing hope and mean-
ing [4]. Dignity therapy offers people who are facing
death an opportunity to create a legacy document. In a
recorded interview, guided by a therapist, a person is in-
vited to recount aspects of his/her life to be remem-
bered, discover purpose and meaning in life, and express
final words or advice to loved ones. The therapist and
client work together to edit the interview transcript, and
the therapy concludes when a final document is pro-
duced which can be shared with family and friends [5].
Dignity therapy often involves family carers who may
provide support during the therapy interview (s) and
editing process, and who may also assist a family mem-
ber weakened by illness in providing the narrative [6].
Family members are also the usual recipients of the doc-
uments, making them an important part of the therapy
even when they are not involved in the document’s cre-
ation. Despite the importance of family members’ in-
volvement in dignity therapy, no studies to date have
examined the impact of the therapy on family members
at the time of the intervention, though dignity therapy
has been shown in prior research to moderate the be-
reavement experience of family members after their
loved one had died [7].
This study examined the effects of dignity therapy on
the family carers of people with motor neurone disease
(MND). A person with MND endures progressive par-
alysis and gradually loses the abilities to move, speak, swal-
low and breathe. There is no treatment or cure. Median
life expectancy is 2–4 years after diagnosis and death is
most often caused by respiratory failure [8]. Family
members caring for people with MND often encounter
exceptional strain during the caregiving experience due to
the rapid and progressive nature of MND coupled with
the incapacitating effects of the disease. Research has doc-
umented the distress and burden experienced by MND
family carers [9-12], and shown the close correlation of
distress levels in patient-carer couples [13,14]. Moreover,
carer burden increases in MND family carers over time as
patient function declines [15-17].
Quality of life may be increased and perceived carer
burden decreased in MND family carers who find posi-
tive meaning [13,14] and have a sense of hope [18].
Dignity therapy is an intervention designed to bolster
hope and meaning and could therefore alleviate per-
ceived burden. Dignity therapy also shows promise toenhance the end of life for people with MND, but its im-
pact on carer distress and burden should be considered
when evaluating its overall impact.
Aims and objectives
The aim of this study was to assess the feasibility, ac-
ceptability, and potential effectiveness of dignity therapy
for family carers of people with MND. The specific ob-
jectives were to assess the impact of dignity therapy on
family carers at the time of the intervention by deter-
mining whether:
a) dignity therapy decreases perceived caregiver
burden, anxiety, depression, and increases hope in
MND family carers;
b) dignity therapy is acceptable to MND family carers;
and
c) it is feasible to involve MND family carers in the
delivery of dignity therapy.
Methods
Study design
This cross-sectional study utilized a single treatment
group and a pre-test post-test design. A control group
was not utilized due to 1) the need to test the feasibility
of dignity therapy with people with MND because they
are a new research population for this intervention [19];
2) access issues to the small MND population in Western
Australia; and 3) ethical concerns over making a poten-
tially useful intervention unavailable to a control group.
More information about the design is available in the
study protocol [20].
Ethical approval
This study was approved by the Curtin University Human
Research Ethics Committee (19/2011).
Setting
MND family carers were recruited from Western Australia
(WA) as a result of outreach from the Motor Neurone
Disease Association of WA (MNDAWA). MNDAWA
provides services to 100–120 diagnosed people with MND
at any one time.
Participants
Family carers of adults diagnosed with MND who could
communicate in English were eligible for the study. En-
rolment occurred between June 2011 and July 2013.
Family carers were invited to participate in the study
when a person with MND enrolled to complete dignity
therapy as a part of a larger research study. If the family
carer did not elect to participate, or if the participant did
not have a family carer, the person with MND remained
eligible to continue with the study. People with MND
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MND could not provide informed consent (based on the
ALS-Cognitive Behavioural Screen [21] and/or the Blessed
Orientation Memory Concentration Test (BOMC) [22]),
were too ill to complete dignity therapy, or were unable to
communicate in English. There was no selection criteria
based on distress levels, stage of disease or proximity to
death.The intervention and study procedures
The intervention was administered by the first author as
part of her PhD studies, who was trained in dignity ther-
apy by Harvey Max Chochinov who developed dignity
therapy [1,4]. The therapy interviews were audio-recorded
and transcribed verbatim. Consistent with the dignity
therapy protocol, some family carers provided support
and assisted with the interview at the request of the per-
son with MND [5]. The researcher shaped the transcribed
interviews using the prescribed editing process [5]. The
legacy document was finalised with the aid of the person
with MND and, where relevant, his or her family carer.
The researcher read the document to each person with
MND and to family members who wished to attend the
reading. Post-testing occurred via mail or a visit from a
second researcher to mitigate response bias. To assure ad-
herence to the dignity therapy protocol, the researcher en-
gaged in regular supervision from Prof. Chochinov and
three experienced researchers (two trained in dignity ther-
apy) reviewed three recordings, transcripts and completed
documents (10%), which were deemed to be adherent.Measures and outcomes
Effectiveness
Outcome data to measure potential effectiveness were
collected from family carers at baseline and one week
after completion of dignity therapy. The primary out-
come is the family carers’ sense of perceived burden,
measured by the Zarit Burden Inventory [23], a reliable
(α = 0.87) validated instrument with a summative score
ranging from 0–48 where higher scores indicate more
burden. Secondary outcomes were: 1) hopefulness
assessed with the Herth Hope Index [24,25], a reliable
(α = 0.97) validated instrument developed for people
confronting terminal illness and their families with a
score ranging from 12–48 and where higher scores in-
dicate more hopefulness; 2) anxiety and 3) depression,
measured with the Hospital Anxiety and Depression
Scale (HADS) [26], an instrument often used with fam-
ily caregivers showing strong reliability (α = 0.89) and
validity. HADS scores range from 0–21 with scores of
8–10 indicating moderate distress and 11–21 indicating
severe distress on both the anxiety and depression sub-
scales.Acceptability
A family feedback questionnaire was used to collect fam-
ily carers’ opinions and experiences of the intervention.
The questionnaire contained 20 questions answered with
a 5-point Likert scale and space for brief explanation.Feasibility
Data were collected about the family carers’ involvement
in the therapy sessions, time taken to conduct the dignity
therapy sessions, any special accommodations made in the
delivery of the intervention when family carers were in-
volved, deviations from the dignity therapy protocol, rea-
sons for non-completion and reasons for attrition.Demographic and health status
Level of impairment of the person with MND and change
in physical function over time was collected from the family
carer using the Amyotrophic Lateral Sclerosis Functional
Rating Scale-R (ALS-FRS) where scores range from 0–48
(lower scores indicating more impairment) [27,28]. Possible
cognitive behavioural impairment of the person with MND
was assessed with the ALS-CBS, which contains a ques-
tionnaire for the person with MND and a separate ques-
tionnaire for the family carer [21]. Demographic data on
age, gender, relationship to the person with MND, children
in the home, caring hours per day, support received, em-
ployment status, spirituality, and health history were also
collected.Analysis
Data were analysed with generalized mixed models
(GLMM) as implemented through SPSS’s (Version 20)
GENLINMIXED procedure. Model parameters were es-
timated with robust standard errors to accommodate
potential violations of the model assumptions. Partici-
pant was treated as a random effect and Time (pre-test,
post-test) was treated as a fixed effect. Caregiver age,
gender, level of education, employment status, spiritual-
ity, relationship length, and caring hours were treated as
fixed effects and analysed individually as potential mod-
erators of the intervention effect. In order to optimise
the likelihood of convergence, a separate GLMM ana-
lysis was run for each of the four outcome measures.
The GLMM maximum likelihood procedure is a full in-
formation estimation procedure that uses all data
present at each assessment point, which reduced sam-
pling bias associated with participant attrition. GPower
(Version 3.1) indicated that 18 participants would be
sufficient to capture relatively ‘large’ (f = .36) pre-post
changes on the outcome variables. Descriptive statistics
were used to summarize demographic variables and
feedback responses.












Relationship to person with MND
Spouse/partner 18
Length of relationship to person with MND
5 to 10 years 1
10 to 25 years 3

















Caring hours per day
Less than 4 hours 5
4 to 8 hours 2
8 to 12 hours 1
More than 12 hours 10
Time since MND diagnosis of family member
Less than one year 4
One to two years 9
Two to three years 2
Three to four years 0
More than four years 3
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Response rate
We recruited 18 family carers from the study group of
29 people with MND. Six people with MND had family
carers who were unwilling or unable to participate
(family carer response rate 75%). The reasons for non-
participation were either the person with MND did not
wish to ask their partner to participate (n = 3), or the
family carer declined stating they did not have the time
(n = 3). Five people with MND had no family carers. All
18 family carers completed the study, though one
returned only the feedback questionnaire and not the
post-test measures.
Demographic information
Family carers (13 women, 5 men) were aged from 38 to
80 years with a median age of 61. All 18 were spouses/
partners who resided with the person with MND. See
Table 1 for more demographic information on our study
group.
Baseline levels of impairment and distress for clients
and carers
People with MND who were cared for by family carers
had low to moderate physical impairment (mean ALS-
FRS score was 32.61). Seven carers cared for family
members who were mildly to moderately cognitively im-
paired as measured by the ALS-CBS. The carers re-
ported moderate baseline levels of distress. Half of the
family carers had moderate (n = 6) to severe (n = 3)
scores for anxiety. Depression was less common with
three carers reporting moderate scores for depression.
Effectiveness
Family carers reported a significant pre-post increase in
burden in conjunction with a significant pre-post de-
crease in the physical functioning of the patient. After
controlling for the pre-post decrease in physical func-
tioning of the person with MND, the pre-post increase
in the carer burden was no longer significant (F [1,32] =
3.32, p = .078, d = .30). There were no significant pre-
post changes in self-reported hopefulness, anxiety, or de-
pression. Pre-test and post-test descriptive statistics and
test statistics for pre-post differences are reported for all
outcome variables in Table 2.
Potential moderators of the intervention effect (care-
giver age, gender, level of education, employment status,
spiritual beliefs, how long carers had known the patient,
caring hours per day, and the number of children living
at home) were individually entered in the regression
model in order to determine whether positive pre-post
changes would emerge at certain levels of the moderator.
There was no significant Moderator x Time interactions
for any outcomes (all ps > .1).
Table 1 Demographic characteristics of the study group
(Continued)
Are you currently being treated for a major medical condition?
No 6
Yes 12








Cognitive screening scores of person with MND
No impairment 11
Suspected mild to moderate impairment 7













Note. aParticipants could list more than one type of support.
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computed to investigate the presence of reliable pre-post
change at the individual rather than group level. The RC
score is the degree to which the person changes on the
outcome variable divided by the standard error of differ-
ence between the pre- and post-test scores. When theTable 2 Mean pre-test post-test scores (and standard de-
viations) for measures of burden, hopefulness, anxiety,





F (1.33) P d
Caregiver burden (ZBI) 12.44 (7.89) 16.29(11.22) 5.58 .024 0.95
Hopefulness (HHI) 38.39 (4.46) 36.71 (4.52) 3.19 .083 0.62
Anxiety (HADS) 7.28 (3.71) 6.88 (4.33) 1.33 .257 0.26
Depression (HADS) 4.17 (3.33) 4.41 (3.91) 0.03 .860 0.39
Physical function
(ALS-FRS)
32.61 (9.76) 30.12 (9.62) 7.00 .012 1.19absolute value of the RC score is greater than 1.96,
(Wise [30] has argued that this value can be reduced in
some situations), it is likely that the post-test score reflects
a real or reliable change. The results suggest potential
prevention effects for anxiety and depression, and both in-
creases and decreases in hopefulness (see Table 3).
Acceptability
The reported benefits and acceptability of dignity ther-
apy to the family carers of people with MND was mixed.
There were many feedback responses indicating it was
helpful, some indicating it was not helpful or even harm-
ful, and some showing ambivalence. Half (n = 9) of the
family carers agreed or strongly agreed that dignity ther-
apy was helpful to them, while about a quarter (n = 4) dis-
agreed or strongly disagreed. More family carers disagreed
than agreed that dignity therapy helped to reduce their
feelings of stress as a carer (n = 5 v n = 6) and an equal
numbers agreed as disagreed that it helped them feel
closer to their partner (n = 6 v n = 6). Some family carers
appeared to find dignity therapy confronting and men-
tioned the attention it brought to their partners’ impend-
ing death.
Family carers were more positive about seeing benefits
to their partner, with 16 agreeing or strongly agreeing
that dignity therapy had been helpful to their family
member, 11 reporting it was an important component of
their care, 10 reporting it had increased meaning in their
partner’s life, and 9 indicating it had helped their family
member prepare for the end of life. Despite mixed feel-
ings about the therapy, 13 believe the document would
be an ongoing source of comfort and 14 would recom-
mend dignity therapy to other people with MND and
their families. The complete results of the feedback
questionnaire are reported in Table 4. Selected com-
ments are available in Table 5.
Feasibility
Twelve of the 18 family carers assisted with the inter-
view and editing process. Ten family carers provided
support by attending the therapy sessions and contribut-
ing to the narrative when requested by their partner, one
served as a proxy for her husband who had lost the abil-
ity to speak and write (completing the entire interviewTable 3 Number of carers showing reliable improvement,
deterioration, and no change for burden, hopefulness,
anxiety, and depression
Outcome Improved Deteriorated No change N
Caregiver burden (ZBI) 0 4 13 17
Hopefulness (HHI) 3 8 6 17
Anxiety (HADS) 2 0 15 17
Depression (HADS) 1 1 15 17
Table 4 Results of the Family Feedback Questionnaire
Item Family carers (N = 18)




DT was helpful to my family member 4.22 0.647 16 0
DT has given my family member a heightened sense of purpose or meaning 3.87 1.060 10 2
DT helped increase my family member’s sense of dignity 3.56 0.984 8 2
DT helped prepare my family member for the end of life, whenever that may occur 3.33 0.970 9 3
DT was an important component of my family member’s care as any other aspect of their
care, including symptom management
3.61 0.979 11 3
DT helped reduce my family member’s suffering 3.22 1.003 7 5
DT helped increase my family member’s hopefulness about the future 3.17 0.857 6 4
The DT document helped me during this time of our life 3.33 1.085 9 4
DT has helped me prepare for the end of life of my family member, whenever that may occur 3.11 0.832 5 4
DT was helpful in reducing my feelings of stress as a carer 3.00 0.907 5 6
DT helped me feel closer to my family member 2.94 0.938 6 6
DT has increased my hopefulness about the future 3.11 0.758 6 4
The DT document will continue to be a source of comfort for my family and me 3.83 0.618 13 0
I would recommend DT to other patients of family members who are dealing with MND 4.00 0.686 14 0
Scoring: 1 strongly disagree, 2 disagree, 3 neither agree or disagree, 4 agree, 5 strongly agree.
Table 5 Selected comments from the family feedback questionnaire
Item Comment
The dignity therapy document helped me during this
time of our life.
“It has provided a source of information and inspiration”.
“I didn’t learn anything about him I didn’t already know”.
“I put my husband first and yet what I read I didn’t feel very appreciated or loved”.
Dignity therapy was helpful in reducing my feelings of
stress as a carer.
“Answering the questions actually increases the stress”.
“When the real suffering begins the stress is going to come no matter what”.
“[There is] more understanding, less tension”.
Dignity therapy helped me feel closer to my family
member.
“Some days we are on the same page, but other days we are upset, angry and not close at all”.
“Nothing replaces 50+ years of constant close companionship and mutual caring”.
“We have always been close but I feel more protective now”.
Dignity therapy has helped me prepare for the end
of life of my family member, whenever that may occur.
“I don’t see how relating his life in a few short pages could prepare me”.
“One thing it did do was focus on the end and not to live and enjoy the journey
along the way the best we can”.
“[It helped] from pushing aside the situation to more acceptance”.
Dignity therapy was helpful to my family member. “Just for him to think of the past and what he has achieved in his life is satisfying”.
“She expressed emotions which she normally suppresses”.
“He enjoyed the opportunity to put memories on paper and have something concrete for
others to read”.
Dignity therapy helped prepare my family member
for the end of life, whenever that may occur.
“[We] recently went on a family holiday and he was able to talk to his children about
his condition”.
“He’s been in denial but has recently come to terms with his diagnosis and the dignity
therapy helped through giving an opportunity to talk about these issues”.
“It has made him face up to his situation and to express himself to family and friends”.
The dignity therapy document will continue to
be a source of comfort for my family and me.
“If we are missing him, we can just read the booklet”.
“The document will provide a basis for reference and reflection”.
“We will treasure his story forever”.
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band), and one carer of a speech impaired wife was sig-
nificantly involved in providing detail and elaborating on
her responses which were written on a whiteboard.
However, not all speech impaired participants required
or requested assistance from their family carers as sev-
eral relied on assisted communication, including email,
to complete the interview and editing. We analysed the
data using descriptive statistics to determine if the dis-
tress levels or acceptability levels differed between the
family carers involved and those not involved in the in-
terviews and editing and we found no significant differ-
ences. The family member who served as a proxy was
the only deviation from the dignity therapy protocol,
though Chochinov and colleagues report instances of
dignity therapy conducted via family proxies and it ap-
pears that this is an acceptable deviation [6].
Generally, individual dignity therapy meetings involv-
ing family carers (n = 12) were of a longer duration than
those completed by the client alone (n = 17). Family
carers added to the session dialog, asked questions, and
often provided refreshments or engaged in other caring
tasks that made their partner more comfortable. All of
these actions extended sessions. Nonetheless, involve-
ment of family carers did not equate to longer legacy
documents. For clients assisted by family carers, docu-
ments were 7 to 47 pages (mean 20.42, SD 13.35), while
documents were 11 to 57 pages (mean 22.94, SD 10.615)
for clients who completed the therapy alone. The number
of sessions required to complete the therapy was fewer in
the group assisted by family carers (mean 3.75 v 4.41), and
the days to complete the intervention slightly more in the
group assisted by family carers (mean 46 v 39).Discussion
Dignity therapy has been shown to moderate the be-
reavement experience in family carers when they were
interviewed 9 to 12 months after death [7], but no previ-
ous studies have looked at the impact of the therapy on
family carers at the time of the intervention. We
hypothesised post-intervention decreases in burden, anx-
iety and depression scores and an increase in hope, but
there were no significant changes. Rather, our population
showed an increase in burden which correlated to a de-
cline in the physical function of the patient during the
study period. This effect is consistent with research of
burden over time in MND family carers [15-17]. With-
out a control group, we are unable to ascertain whether
dignity therapy had a prevention effect against expected
increases in burden, anxiety, and depression, or a decline
in hopefulness.
The individual results on anxiety and depression are
more encouraging and suggest that dignity therapy hasthe potential to decrease anxiety and depression in family
carers who are experiencing moderate to high levels of
distress. This is similar to the findings for terminally ill
cancer patients, where distressed individuals had a de-
crease in anxiety and depression scores [2], but those with
low baseline levels of distress showed no change [1].
Acceptability of dignity therapy was mixed. Family
carers felt that the therapy provided a benefit to their fam-
ily members and that the document would help them in
bereavement, and most rated the experience as satisfac-
tory and one they would recommend to others. Whether
a family carer was directly involved in the therapy had lit-
tle impact on the acceptability or feasibility of dignity ther-
apy. Rather, the comments provided on the feedback
questionnaire suggest that family carers’ level of accept-
ance of their partner’s imminent death, or the quality of
the relationship between family carer and partner, may
lead to dignity therapy having a potentially negative im-
pact on family carers at the time of the intervention.
Strengths and limitations
The strengths of this study were the high response rate
and high completion rate of MND family carers, the use of
MND-specific cognitive and health status measures, and
the demographic characteristics of the sample are generally
representative of MND family carers. The limitations in-
clude inadequate power to discover small to moderate ef-
fects, mild to moderate levels of distress at baseline, and
the lack of a control group. The study group may not be
representative of all MND family carers because those who
declined to participate may have been more distressed, and
people with MND with severe cognitive impairment and
their family carers were excluded from the study.
Implications for future research
The effectiveness of dignity therapy in decreasing per-
ceived caregiver burden, anxiety or depression, or in-
creasing hopefulness in MND family carers could not be
determined in this study. A randomised controlled trial
with a greater number of participants is needed, perhaps
incorporating a stepped-wedge or cluster design. An ex-
perimental study focusing on distressed family carers is
warranted to determine if dignity therapy has the poten-
tial to decrease anxiety and depression. A qualitative
study with family carers is indicated to explore more
fully the mixed acceptability results provided in the feed-
back questionnaire. Further, a longitudinal study would
determine if the document was helpful to carers follow-
ing bereavement.
Ethical challenges
Dignity therapy may trigger emotional upset in people
with MND who are experiencing emotional lability and
this was frequently encountered. Emotional lability, also
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which has the potential to cause distress to the person
with MND and their family carer if it is not treated sen-
sitively and therapeutically. In our study, we provided a
supportive and safe environment, information and
psycho-education, and normalised the symptom. Other
ethical challenges encountered include negotiating com-
plex relationships of participants and family carers, mini-
mising harm to both parties as well as extended family
members through what was written in (or left out of )
the generativity document, and balancing the interests of
the family carers with those of the patient. These chal-
lenges suggest that the skillful application of dignity ther-
apy by a trained psychotherapist who is knowledgeable
about MND is paramount in any future research.
Conclusions
The findings of this study suggest that dignity therapy is
not likely to alleviate the burden encountered by MND
family carers during caring, but it may have the ability to
decrease or moderate anxiety and depression in dis-
tressed MND family carers. Dignity therapy is feasible
and generally acceptable to family carers of people with
MND, who recognize benefits to their ill family member
and also the potential benefits to themselves during be-
reavement as a result of having the legacy document.
Comments from carers indicate that it is important for a
dignity therapist to be aware of acceptance levels and
dynamics in partner relationships in order to best pro-
vide a satisfactory experience for family carers.
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